MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.nano.2021.102445

Медицинская библиотека · Nanomedicine : nanotechnology, biology, and medicine · 2021

Nano-multilamellar lipid vesicles loaded with a recombinant form of the chikungunya virus E2 protein improve the induction of virus-neutralizing antibodies.

Venceslau-Carvalho Aléxia Adrianne, Teixeira de Pinho Favaro Marianna, Ramos Pereira Lennon, Rodrigues-Jesus Mônica Josiane, Santos Pereira Samuel, Andreata-Santos Robert, Dos Santos Alves Rúbens Prince, Castro-Amarante Maria Fernanda, Bitencourt Rodrigues Karine, Ramos da Silva Jamile, Rahal Guaragna Machado Rafael, Dos Passos Cunha Marielton, Marinho de Andrade Zanotto Paolo, Luzetti Fotoran Wesley, Wunderlich Gerhard, Durigon Edison Luiz, de Souza Ferreira Luís Carlos

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Chikungunya virus (CHIKV) is responsible for a self-limited illness that can evolve into long-lasting painful joint inflammation. In this study, we report a novel experimental CHIKV vaccine formulation of lipid nanoparticles loaded with a recombinant protein derived from the E2 structural protein. This antigen fragment, designated ∆E2.1, maintained the antigenicity of the native viral protein and was specifically recognized by antibodies induced in CHIKV-infected patients. The antigen has been formulated into nanoparticles consisting of nano-multilamellar vesicles (NMVs) combined with the adjuvant monophosphoryl lipid A (MPLA). The vaccine formulation demonstrated a depot effect, leading to controlled antigen release, and induced strong antibody responses significantly higher than in mice immunized with the purified protein combined with the adjuvant. More relevantly, E2-specific antibodies raised in mice immunized with ∆E2.1-loaded NMV-MPLA neutralized CHIKV under in vitro conditions. Taken together, the results demonstrated that the new nanoparticle-based vaccine formulation represents a promising approach for the development of effective anti-CHIKV vaccines.

Для цитирования: Venceslau-Carvalho Aléxia Adrianne, Teixeira de Pinho Favaro Marianna, Ramos Pereira Lennon, Rodrigues-Jesus Mônica Josiane, Santos Pereira Samuel, Andreata-Santos Robert, Dos Santos Alves Rúbens Prince, Castro-Amarante Maria Fernanda, Bitencourt Rodrigues Karine, Ramos da Silva Jamile, Rahal Guaragna Machado Rafael, Dos Passos Cunha Marielton, Marinho de Andrade Zanotto Paolo, Luzetti Fotoran Wesley, Wunderlich Gerhard, Durigon Edison Luiz, de Souza Ferreira Luís Carlos. Nano-multilamellar lipid vesicles loaded with a recombinant form of the chikungunya virus E2 protein improve the induction of virus-neutralizing antibodies.. Nanomedicine : nanotechnology, biology, and medicine. 2021. DOI: 10.1016/j.nano.2021.102445.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.